Back to Search
Start Over
[p53 and Ki67 expression in specimens of radical prostatectomy. Relationship with clinico-pathologic data and survival].
- Source :
-
Actas urologicas espanolas [Actas Urol Esp] 2000 Apr; Vol. 24 (4), pp. 307-13. - Publication Year :
- 2000
-
Abstract
- Objectives: Analysis in T1-T2 prostate cancer of the following: a) Whether there is a relationship between Ki67 and p53 over-expression, and clinico-pathological variables. b) Whether that expression influences on progression free survival.<br />Material and Methods: The study included 68 patients diagnosed with T1-T2 prostate cancer undergoing radical prostatectomy and immunohistochemical testing of Ki67 and p53 in the prostatectomy specimen, indicating in each case the percentage of stained cells. The study was carried out by: a) Comparison of means between percentage groups of stained cells. b) Grouping patients according to expression percentage. In Ki67, a comparison is made between those expressing 0-5% vs > 5%. In p53, those expressing (0%) vs > 1%. Mean follow-up: 20 months; median: 16 months.<br />Results: Mean expression of Ki67 is 7.2% (57% cases > 5%). 60% do not over-express p53; mean 3.65; only 15% is higher than 5%. There is a correlation between Ki67 and p53 (p: 0.002), but not to PSA. Ki67 expression is related with a poorer pathological stage (p: 0.07) and greater biochemical progression (p: 0.07), and it has a significant influence on progression free survival in both the univariate (at three years 76% vs 48%; p: 0.04) and the multivariate studies (RR: 5.7; p: 0.005). Over-expression of p53 is not related to any clinico-pathological variable, and does not influence progression free survival.
Details
- Language :
- Spanish; Castilian
- ISSN :
- 0210-4806
- Volume :
- 24
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Actas urologicas espanolas
- Publication Type :
- Academic Journal
- Accession number :
- 14964088
- Full Text :
- https://doi.org/10.1016/s0210-4806(00)72453-3